Specifically, when controlling for the genetic cause of FH, observed differences in LDL-c could contribute to the identification of genetic variants that increase susceptibility to LDL accumulation and atherogenicity beyond LDLR. This evidence concerns the gene LDLR and familial hyperaldosteronism.